What this means
This study plans to combine frailty and patient-reported health measures to better predict kidney outcomes. It has not started recruiting, so it cannot yet tell us whether the approach works.
Plain-English summary written by an AI model from the registry listing.
- Status
- Opening soon
- Who can join
- Ages 75 and over
- Where
- 2 sites
The science
- Registered title
- Prognostic Value of a Multidimensional Assessment for Survival in Elderly Patients With CKD 4B/5
- Trial ID
- NCT06825234 ↗
- Phase
- Not applicable
- Study type
- observational
- Conditions
- Chronic Kidney Disease Stage 5, Chronic Kidney Disease Stage 4B
- Sponsor
- Centre Hospitalier Universitaire de Besancon
- Ages
- 75 Years to no maximum
- Dates
- First posted Feb 13, 2025 · updated May 1, 2025
Registry summary
The aim of this study is to determine a multidimensional signature (integrating frailty and patient-reported outcomes measures (PROMs) at entry into stage 4B/5 CKD) to improve prediction of renal death (dialysis, transplantation, conservative management, death).
Sites (2)
- Besançon University Hospital, Besançon, France
- Tours University Hospital, Tours, France